The cellular/molecular abnormalities of Alzheimer's disease are also present in older patients with Down's syndrome and in some old nondemented individuals. To evaluate these changes, it is essential to have optimally prepared tissues from clinically well-characterized cases who lack other confounding illnesses. Core C includes a staff of neuropathologists, neuroanatomists, other basic scientists, a clinical coordinator, and technical personnel. The professional staff of Core C arranges autopsies, neuropathological diagnosis, and coordinates the use of tissues for research. These scientists also direct the technical staff and laboratory facilities involved in histology, immunocytochemistry, neurochemistry, receptor autoradiography, and computer-assisted imaging (i.e., for morphometry, autoradiography, in situ hybridization, and Northern and Western blots). The clinical coordinator works with patients, families, and clinicians to facilitate autopsies. The technical staff assists with autopsy procedures and brain dissections, performs histological processing and staining of diagnostic and research material, accessions and stores tissues for distribution to investigators, assists with preparation of tissues or neurochemical and autoradiographic studies, and maintains and operates the image analysis systems. Finally, members of the Core C staff participate in projects of the Consorium to Establish a Registry for Alzheimer's Disease (CERAD) and contribute significantly to the training of physicians and scientists on issues relevant to aging, Alzheimer's disease, and Down's syndrome.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005146-07
Application #
3814002
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications